| JOURNAL HOME | CME HOME | THIS MONTH | PAST ISSUES | ETOC | COLLECTIONS |
| AUTHORS | REVIEWERS | EDITORIAL BOARD | FEEDBACK | RSS | HELP |
| ||||||||||||||
| ||||||||||||||
|
|
|
|
||||||||||||
|
||||||||||||||
Department of Anesthesiology, Queen’s University, Kingston, Ontario
Address correspondence and reprint requests to Joel L. Parlow, MD, Department of Anesthesiology, Kingston General Hospital, 76 Stuart St., Kingston, Ontario, K7L 2V7. Address e-mail to parlowj{at}post.queensu.ca
Postoperative nausea and vomiting (PONV) occurs frequently with the use of intrathecal morphine. We studied the ability of a single, small dose of the inexpensive, long-acting, dopamine receptor-blocking drug, haloperidol, to prevent PONV after spinal anesthesia using local anesthetic with morphine 0.3 mg. One-hundred-eight adult patients undergoing elective lower limb orthopedic or endoscopic urologic procedures under spinal anesthesia were randomized to receive IM haloperidol 1 mg (H1), haloperidol 2 mg (H2), or placebo (P) after an intrathecal injection. Patients were assessed for 24 h after surgery, with treatment failure being defined as nausea >1 on a 10-cm visual analog scale or any vomiting or request for rescue antiemetic. Most treatment failures occurred during the first 12 h (60% overall), and haloperidol led to a dose-dependent decrease in PONV (first 12 h: 76% P, 56% H1, and 50% H2; P = 0.012). A history of PONV was strongly associated with PONV in the current study, regardless of treatment group. There were no dystonic reactions noted to either dose of haloperidol. We conclude that haloperidol reduces the incidence of PONV after intrathecal morphine, although this incidence remains a significant problem even with treatment.
IMPLICATIONS: In this randomized, double-blinded, placebo-controlled trial, a single, small IM dose of haloperidol 1 mg or 2 mg reduced the incidence of postoperative nausea and vomiting after spinal anesthesia with local anesthetic and intrathecal morphine.
This article has been cited by other articles:
|
|
 |
|
  Y. L. Yang, H. Y. Lai, J. J. Wang, P. K. Wang, T. Y. Chen, C. C. Chu, and Y. Lee The timing of haloperidol administration does not affect its prophylactic antiemetic efficacy: [Le moment choisi pour l'administration d'haloperidol n'affecte pas son efficacite anti-emetique prophylactique] Can J Anesth, May 1, 2008; 55(5): 270 - 275. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-C. Chu, J.-P. Shieh, J.-I. Tzeng, J.-Y. Chen, Y. Lee, S.-T. Ho, and J.-J. Wang The Prophylactic Effect of Haloperidol Plus Dexamethasone on Postoperative Nausea and Vomiting in Patients Undergoing Laparoscopically Assisted Vaginal Hysterectomy Anesth. Analg., May 1, 2008; 106(5): 1402 - 1406. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. S. Habib and T. J. Gan PRO: The Food and Drug Administration Black Box Warning on Droperidol Is Not Justified Anesth. Analg., May 1, 2008; 106(5): 1414 - 1417. [Full Text] [PDF]
|
|
|
|
|
|
Y. Lee, P. K. Wang, H. Y. Lai, Y. L. Yang, C. C. Chu, and J. J. Wang Haloperidol is as effective as ondansetron for preventing postoperative nausea and vomiting: [L'haloperidol est aussi efficace que l'ondansetron dans la prevention des nausees et vomissements postoperatoires] Can J Anesth, May 1, 2007; 54(5): 349 - 354. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-D. Roy, L. Massicotte, M.-P. Sassine, R. F. Seal, and A. Roy A Comparison of Intrathecal Morphine/Fentanyl and Patient-Controlled Analgesia with Patient-Controlled Analgesia Alone for Analgesia After Liver Resection Anesth. Analg., October 1, 2006; 103(4): 990 - 994. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Pirat, S. F. Tuncay, A. Torgay, S. Candan, and G. Arslan Ondansetron, Orally Disintegrating Tablets Versus Intravenous Injection for Prevention of Intrathecal Morphine-Induced Nausea, Vomiting, and Pruritus in Young Males Anesth. Analg., November 1, 2005; 101(5): 1330 - 1336. [Abstract] [Full Text] [PDF]
|
|
|
